| Literature DB >> 29035554 |
Emily H Pilkington1, May Lai1, Xinwei Ge2, William J Stanley3,4, Bo Wang2, Miaoyi Wang1, Aleksandr Kakinen1, Marc-Antonie Sani5, Michael R Whittaker1, Esteban N Gurzov3,4, Feng Ding2, John F Quinn1, Thomas P Davis1,6, Pu Chun Ke1.
Abstract
Protein aggregation into amyloid fibrils is a ubiquitous phenomenon across the spectrum of neurodegenerative disorders and type 2 diabetes. A common strategy against amyloidogenesis is to minimize the populations of toxic oligomers and protofibrils by inhibiting protein aggregation with small molecules or nanoparticles. However, melanin synthesis in nature is realized by accelerated protein fibrillation to circumvent accumulation of toxic intermediates. Accordingly, we designed and demonstrated the use of star-shaped poly(2-hydroxyethyl acrylate) (PHEA) nanostructures for promoting aggregation while ameliorating the toxicity of human islet amyloid polypeptide (IAPP), the peptide involved in glycemic control and the pathology of type 2 diabetes. The binding of PHEA elevated the β-sheet content in IAPP aggregates while rendering a new morphology of "stelliform" amyloids originating from the polymers. Atomistic molecular dynamics simulations revealed that the PHEA arms served as rodlike scaffolds for IAPP binding and subsequently accelerated IAPP aggregation by increased local peptide concentration. The tertiary structure of the star nanoparticles was found to be essential for driving the specific interactions required to impel the accelerated IAPP aggregation. This study sheds new light on the structure-toxicity relationship of IAPP and points to the potential of exploiting star polymers as a new class of therapeutic agents against amyloidogenesis.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29035554 PMCID: PMC5729549 DOI: 10.1021/acs.biomac.7b01301
Source DB: PubMed Journal: Biomacromolecules ISSN: 1525-7797 Impact factor: 6.988
Figure 1Synthesis and preliminary characterization of PHEA stars via RAFT polymerization. (A) Synthesis of PHEA stars using a symmetrical RAFT agent. (B) Gel permeation chromatograms for the PHEA arm (orange) and star (gray). (C) Size distribution by number from dynamic light scattering for PHEA stars.
Figure 2(A) 1H NMR spectrum of purified PHEA stars recorded in DMSO-d6 (400 MHz). The phenyl end-groups are evident at δ = 7.2–7.3 ppm. (B) FTIR-ATR spectra for the PHEA arm (orange) and star (blue).
Figure 3(A) ThT fluorescence of IAPP in the presence of PHEA stars over 24 h. Dotted lines represent sigmoidal curve fitting (least-squares fit); error is SEM (n = 2). (B) Secondary structure transitions in IAPP mapped by circular dichroism at 0, 2.5, and 24 h time points. Lines are intended to guide the eye. The concentration of IAPP in all experiments is 25 μM.
Figure 4(A) TEM imaging of fibrillating IAPP (IAPP) and mature IAPP amyloids (Amyloid) in the presence and absence of PHEA stars after 24 h incubation. Stelliform amyloids are seen at PHEA:IAPP 1:5. Scale = 100 nm. (B) Structural analysis of amyloid fibrils visualized in (A). IAPP concentration in all experiments is 25 μM.
Figure 5Protective effect of PHEA stars against IAPP-mediated cytotoxicity in pancreatic beta cells and islets. (A) In vitro cytotoxicity of fibrillating IAPP and mature IAPP amyloids in the presence and absence of PHEA in βTC6 cells over 24 h. Error = SEM (n = 3). (B) Ex vivo cytotoxicity of fibrillating IAPP and IAPP:PHEA at a 1:5 molar ratio in mouse islets after 48 h incubation. Flow cytometry data is representative of n = 5 experiments summarized in the graph. Error = SEM. ****p < 0.0001, one-way ANOVA with Tukey’s correction.
Figure 6Aggregation free energy landscapes of IAPP without (A) and with (B) PHEA. Three-dimensional potentials of mean force (PMFs) with respect to IAPP oligomer size and degree of fibrillization were used to derive the free energy landscapes in front and top views. Snapshot structures with IAPP in cartoon and PHEA polymers in stick are shown to illustrate the basins and saddles of the energy landscapes.